Want to join the conversation?
$XYL's Applied Water segment delivered 2Q16 orders of $361MM, up 1% organically over 2Q15 and entered 3Q16 with total backlog of $180MM. In this segment, the company saw a modest improvement in its weekly order rates over the course of this past quarter. Revenue was $366MM, flat organically vs. the prior year.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?